Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Urinary Bladder Neoplasms × tocilizumab × Clear all

Sponsor

Conditions

Arthritis, Rheumatoid 4 Lymphoma, B-Cell 2 Hematologic Neoplasms 2 Breast Neoplasms 2 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Solid Tumors 1 Sarcoma, Kaposi 1 Respiratory Tract Infections 1 Respiratory Distress Syndrome 1 Pneumonia 1 Pancreatic Neoplasms 1 Pancreatic Adenocarcinoma 1 Nasopharyngeal Neoplasms 1 Multi-centric Castleman's Disease 1 Mesothelioma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Liver Neoplasms 1 Kidney Neoplasms 1 Esophageal Neoplasms 1 Castleman Disease 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Hepatocellular 1 COVID-19 1 Biliary Tract Neoplasms 1 Acquired Immunodeficiency Syndrome 1

Interventions

Gemcitabine 42 Cisplatin 29 pembrolizumab 25 Paclitaxel 12 Docetaxel 12 atezolizumab 11 Nivolumab 10 Mitomycin 10 avelumab 9 Carboplatin 9 Cystectomy 8 durvalumab 7 Sunitinib 7 Doxorubicin 6 BCG Vaccine 6 5-aminolevulinic acid hexyl ester 6 apaziquone 5 Vinblastine 5 Platinum 5 Methotrexate 5 Albumin-Bound Paclitaxel 5 Taxes 4 Standard of Care 4 Radiotherapy 4 Radiation 4 Fluorouracil 4 Erlotinib Hydrochloride 4 1,2-diaminocyclohexaneplatinum II citrate 4 vinflunine 3 tisotumab vedotin 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡